135 related articles for article (PubMed ID: 31014976)
1. [Alitretinoin (Toctino
Vrignaud L; Simon C; Agier MS; Théophile H; Gras-Champel V; Beau-Salinas F; Lengellé C; Jonville-Béra AP
Therapie; 2019 Oct; 74(5):513-519. PubMed ID: 31014976
[TBL] [Abstract][Full Text] [Related]
2. [Alitretinoin (Toctino®): Recent pharmacovigilance data].
Schmutz JL
Ann Dermatol Venereol; 2020 Apr; 147(4):329-330. PubMed ID: 32145989
[No Abstract] [Full Text] [Related]
3. Psychiatric disorders, acne and systemic retinoids: comparison of risks.
Le Moigne M; Bulteau S; Grall-Bronnec M; Gerardin M; Fournier JP; Jonville-Bera AP; Jolliet P; Dreno B; Victorri-Vigneau C
Expert Opin Drug Saf; 2017 Sep; 16(9):989-995. PubMed ID: 28657366
[TBL] [Abstract][Full Text] [Related]
4. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Morris M; Schifano L; Fong R; Graff O
J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
[TBL] [Abstract][Full Text] [Related]
5. An Update on the Use of Alitretinoin for Chronic Hand Dermatitis in a Dermatology Practice Setting.
Crowley EL; Sayeau RL; Gooderham MJ
J Cutan Med Surg; 2018; 22(1):102-103. PubMed ID: 29309241
[No Abstract] [Full Text] [Related]
6. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
7. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
8. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
10. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
11. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey.
Bernard N; Jantzem H; Becker M; Pecriaux C; Bénard-Laribière A; Montastruc JL; Descotes J; Vial T;
BJOG; 2015 Aug; 122(9):1244-51. PubMed ID: 25761676
[TBL] [Abstract][Full Text] [Related]
12. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Efficacy Between Cyclosporine and Alitretinoin in Patients With Chronic Hand Eczema.
Jang JH; Joh HC; Song CH; Kim KY; Jue MS; Ro YS; Ko JY
Dermatitis; 2024; 35(3):258-265. PubMed ID: 37870578
[No Abstract] [Full Text] [Related]
14. [Isotretinoin: compliance with recommendations in childbearing women].
Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.
Halioua B; Paul C; Berbis P; Cambazard F; Doutre MS; Joly P; Richard MA; Aubin C; Gruber A; Chosidow O
Eur J Dermatol; 2019 Feb; 29(1):59-66. PubMed ID: 30827949
[TBL] [Abstract][Full Text] [Related]
16. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of etifoxine: A French pharmacovigilance survey.
Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
[TBL] [Abstract][Full Text] [Related]
18. Alitretinoin can be a good treatment option for idiopathic recalcitrant trachyonychia in adults: an open-label study.
Shin K; Kim TW; Park SM; Lee HJ; Jin H; You HS; Shim WH; Kim GW; Kim HS; Ko HC; Kim BS; Kim MB
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1810-1814. PubMed ID: 29704273
[TBL] [Abstract][Full Text] [Related]
19. Low levels of alitretinoin in seminal fluids after repeated oral doses in healthy men.
Schmitt-Hoffmann AH; Roos B; Sauer J; Brown T; Weidekamm E; Meyer I; Schleimer M; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():12-7. PubMed ID: 21443599
[TBL] [Abstract][Full Text] [Related]
20. Four-year data from use of the nut and soya allergy testing protocol before treatment with isotretinoin and alitretinoin.
Alden K; Chowdhury MMU; Williams PE; Kalavala M
Clin Exp Dermatol; 2020 Jul; 45(5):627-629. PubMed ID: 32149418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
